Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Emerging-market sovereign and corporate bond issuance that surged at the start of the year has largely paused as volatility linked to the Iran conflict drives up borrowing costs and prompts investor caution. While a handful of oil-linked issuers have successfully tapped markets, many countries face a funding limbo as secondary-market dynamics, outf…
Major cybersecurity stocks declined sharply on Friday after reports emerged that descriptions of Anthropic’s upcoming AI model, codenamed Claude Mythos, were exposed in a publicly accessible data cache. The startup attributed the exposure to 'human error' in its content management configuration. The draft suggested a new, larger model tier called '…
Structure Therapeutics (GPCR) just delivered Phase 2 data for aleniglipron that put oral GLP-1 efficacy in the same neighborhood as injectables. The market has priced a lot of optimism into the stock, but given the company's $3.27B market cap, strong technical oversold signals, and a clear Phase 3 path in H2 2026, there is a structured, asymmetric …
Ocean Power Technologies announced securing a contract to deliver a fully integrated WAM-V autonomous surface vehicle to a new underwater research customer in the Nordics. This order marks an expansion of the company's presence in the Nordic region and demonstrates ongoing demand across multiple sectors including defense, surface inspections, and u…
Cyabra, a company dedicated to identifying coordinated manipulation in online narratives and protecting digital trust, has completed its business combination with Trailblazer Merger Corp. Cyabra's common stock is set to begin trading on Nasdaq on March 27, 2026, under the ticker CYAB. The combination supports Cyabra's mission to combat disinformati…
Vail Resorts (MTN) just had a brutal ski season but the underlying business - high-margin pass revenue, recurring lodging and real estate cash flows, and a strong FCF profile - still supports owning the name through the trough. At $130, MTN yields nearly 7%, trades at a mid-teens P/E, and carries an enterprise value that implies roughly $2.55B of n…
Quantum BioPharma Ltd. announced its audited financial results for 2025 showing a strong balance sheet with $11.3 million in cash and digital assets, improved working capital, and reduced operating expenses. The company completed Phase 1 toxicology studies for its oral MS drug candidate Lucid-MS, advancing toward Phase 2 trials. Additionally, clini…
Kepler has upgraded SOL from Hold to Buy and lifted its price target to EUR56.50, citing robust fiscal 2025 results, margin expansion, and a favourable near-term M&A backdrop. The Italian chemicals group delivered double-digit EBITDA and net profit growth, while Kepler increased its 2026 sales and EBITDA forecasts and raised EPS estimates through 2…
Denmark's Prime Minister Mette Frederiksen and her Social Democrats have begun talks to form a new coalition after a heavy electoral loss left her centrist-right coalition unable to continue. Although her party remains the largest in the 179-seat Folketing, it fell to 38 seats and the left-leaning bloc holds 84 seats, short of the 90 needed for a m…
Inflection Point Acquisition Corp. VI, a special purpose acquisition company (SPAC), announced the pricing of its IPO, offering 22 million units at $10 each, expected to raise $220 million. The units will trade on Nasdaq under ticker IPFXU, with separate trading expected for shares and warrants under IPFX and IPFXW respectively. The company aims to…
Hydrofarm Holdings Group, Inc. announced its fourth quarter and full year 2025 financial results showing a 32.7% reduction in net sales for Q4 compared to the prior year, driven by industry oversupply and price decreases. Despite improvements in gross profit margins and reduced operating expenses due to restructuring efforts, the company reported a…
Glucotrack, Inc. announced significant progress towards filing an Investigational Device Exemption (IDE) with the U.S. FDA in Q2 2026 to initiate a U.S. clinical trial for its implantable continuous blood glucose monitoring system. Following successful first-in-human trials in Brazil and a follow-up study in Australia, the company completed key tri…
Coeur Mining (CDE) recently closed its New Gold acquisition and announced 2026 guidance of 680k-815k gold ounces, a $750M share repurchase and a new dividend. Balance-sheet strength (cash ~$1.41B, FCF ~$665.7M) and 4.4M oz of proven and probable gold reserves ($22.1B implied valuation at $5,020/oz) are underappreciated by the market. Technicals sho…
JBS trades at roughly $16.76 with a market cap near $17.8B, a PE near 8.8 and 52-week range $12.37–$18.02. Rising beef prices, successful note exchange activity and constructive technicals create an attractive swing trade: entry $16.76, stop $15.00, target $19.00 over ~45 trading days.
Senti Biosciences announced its fourth quarter and full year 2025 financial results, marking significant progress in its clinical pipeline, particularly with SENTI-202 for relapsed/refractory acute myeloid leukemia (AML). The company reported positive preliminary Phase 1 clinical data, received FDA Regenerative Medicine Advanced Therapy designation…
IREN is building GPU-ready, grid-connected data center capacity in renewable-rich regions and has already converted that advantage into big contracts and rapid revenue growth. The stock has pulled back after a capital raise and worries about utilization, creating a trade opportunity for disciplined, event-driven traders who believe IREN can scale i…
Marcopolo is leaning on international markets to make up for a softer outlook at home in 2026, boosting exports across Latin America and preparing a push into European markets. International operations accounted for nearly half of the company's net revenue in 2025, and executives say they are seeing momentum in multiple neighboring countries while …
Norwegian Cruise Line Holdings Ltd. announced the appointment of John W. Chidsey as President and CEO, effective February 2026, accompanied by a new employment agreement and a $48 million restricted share unit award designed to incentivize long-term shareholder value creation over four years. The equity award includes performance-based and time-ves…
U.S. ambassador to the European Union Andrew Puzder told CNBC that the EU risks excluding itself from the artificial intelligence economy if it imposes heavy regulation and fines on American technology companies. Puzder said participation in AI requires data centers, data flows and access to U.S. AI hardware, and cautioned that shifting regulatory …
Trade ministers gathered in Yaounde, Cameroon, remain committed to negotiating World Trade Organization reforms, but deep divisions persist, notably between the United States and India. Key sticking points include whether to adopt a detailed reform workplan, extension of an e-commerce moratorium, the inclusion of an Investment Facilitation for Deve…
Goldman Sachs said in a Friday note that a cooling of geopolitical tensions could allow global equities to resume recent outperformance and put downward pressure on the U.S. dollar. The bank argued markets are currently balancing high inflation against weak growth while pricing in risks from the Iran conflict and a possible sustained energy shock. …
Profound Medical Corp. announced that Texas Prostate, led by Dr. James Cochran, has reached the milestone of performing 100 TULSA Procedures using Profound's TULSA-PRO system at Dallas Medical Center. The collaboration has increased procedure volume by 500% since transitioning to a Medicare payment model, accelerating adoption of this innovative, M…
Goldman Sachs downgraded Beiersdorf (ETR:BEIG) from Buy to Neutral following FY25 results, trimming earnings forecasts and reducing its FY26 revenue estimate to €9.86 billion. The bank flagged decelerating NIVEA sales, weakness at La Prairie and margin headwinds driven by raw material costs, foreign exchange and limited operating leverage. It also …
Clearmind Medicine Inc., a Nasdaq-listed clinical-stage biotech company, announced the filing of a patent application in India for next-generation psychedelic compounds aimed at treating mental health disorders and addiction. This move expands the company's global intellectual property portfolio and builds on its licensing agreement with Yissum Res…
Social media and prediction markets have lit up around the prospect of a SpaceX public offering, with users placing millions of dollars on the likely ticker, listing venue and valuation. Market wagers, shifting odds for a single-letter ticker, and discussions about an unusually large retail allocation underscore the unusual investor focus on the pr…
